MedPath

Acceptability and Tolerance Study of a Plant-based Tube Feed

Recruiting
Conditions
Nutrition Disorders
Interventions
Dietary Supplement: Compleat plant protein tube feed
Registration Number
NCT06209593
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

This is a single arm, prospective, multi-centre study to evaluate the gastrointestinal tolerance and compliance over a 7-day period with a plant based tube feed.

Detailed Description

Enterally fed adults who are assessed by the Health Care Professional/dietitian as requiring an adult plant- based high-energy, enteral formula will be recruited. Data from 15 participants are required in order to submit an application to the UK Advisory Committee on Borderline Substances (ACBS) for product registration

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Patients 16 years and over and adults requiring a plant- based enteral tube feed (taking 50% or more of energy needs from their feeding tube) as part of their dietary management for disease related malnutrition
  • Patients well-established and stable on current polymeric enteral tube feed.
  • Willingly given, written, informed consent from patient
Exclusion Criteria
  • Inability to comply with the study protocol, in the opinion of the investigator
  • Under 16 years of age
  • Patients on total parenteral nutrition
  • Known food allergies to any ingredients including patients who have an allergy to milk protein e.g IgE and non- mediated as product contains traces of milk and allergy to peanuts due to the pea protein
  • Patients with significant renal or hepatic impairment
  • Participation in another interventional study within 2 weeks of this study.
  • Patients with known or suspected ileus or mechanical bowel obstruction

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients well established on tube feeds will act as their own controlCompleat plant protein tube feedEach participant will receive the new trial feed a nutritionally complete standard enteral tube feed for a period of 7 days. The new trial feed is a food for special medical purposes for use under medical supervision. The Health Care Professional/ dietitian will determine the feeding regimen on an individual basis and the enteral formula will be provided via a feeding tube.
Primary Outcome Measures
NameTimeMethod
Baseline assessment and daily recording during intervention up to day 7 measuring Gastrointestinal tolerance7 days

Diarrhoea, constipation, reflux, vomiting, wind, boating

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Nu

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath